What is Generate Biomedicines, Inc. 's net investment in lease?

Generate Biomedicines, Inc. (GENB) reported net investment in lease of $57.77M in Q1 2026.

Generate Biomedicines, Inc. GENB Net Investment in Lease

Net Investment in Lease at other companies

PNC Financial ServicesPNC

$6.64B+6.6%

Wintrust FinancialWTFC

$362.77M+29.3%

WelltowerWELL

$57.8M—

Gaming and Leisure PropertiesGLPI

$250.51M+2.0%

Wells Fargo & CompanyWFC

$1T+11.5%

Regency CentersREG

$16.79M+1.6%

Other financials

Income statement

See full

Revenue$7.2M-18.1%

Operating income-$64.1M-33.1%

Net income-$61.4M-47.4%

EPS (diluted)-$1.07+34.0%

Balance sheet

See full

Cash & equivalents$160.6M-27.2%

Total debt$65.6M—

Total equity$514.8M+209%

Total assets$625.7M—

Cash flow

See full

Operating cash flow-$80.4M-51.2%

CapEx$3.8M+403%

Free cash flow-$84.2M-56.1%

Valuation

See full

Market cap$1.86B—

Enterprise value$1.76B—

Returns & leverage

See full

Debt / equity0.1×—

Current ratio9.2×—

Where this comes from

Reported directly by Generate Biomedicines, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The official record: Generate Biomedicines, Inc. ’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Generate Biomedicines, Inc. 's net investment in lease.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Generate Biomedicines, Inc. 's net investment in lease?: Generate Biomedicines, Inc. (GENB) reported net investment in lease of $57.77M in Q1 2026.